APG Asset Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,500
Closed -$478K 975
2021
Q4
$478K Buy
+2,500
New +$524K ﹤0.01% 862
2020
Q4
Sell
-51,828
Closed -$4.94M 995
2020
Q3
$4.94M Sell
51,828
-31,578
-38% -$3.65M 0.01% 668
2020
Q2
$6.91M Sell
83,406
-162,749
-66% -$13.8M 0.01% 627
2020
Q1
$18.1M Sell
246,155
-403,300
-62% -$35M 0.04% 433
2019
Q4
$48.6M Buy
649,455
+23,665
+4% +$1.83M 0.08% 279
2019
Q3
$48.2M Buy
625,790
+14,377
+2% +$1.09M 0.08% 279
2019
Q2
$35.1M Buy
611,413
+456,413
+294% +$26.3M 0.06% 317
2019
Q1
$8.14M Buy
155,000
+142,900
+1,181% +$8.54M 0.01% 540
2018
Q4
$560K Buy
+12,100
New +$664K ﹤0.01% 813

Other funds holding MEDP

APG Asset Management's MEDP Position: Q1 2022 in Review

APG Asset Management sold out of Medpace (MEDP) in Q1 2022, closing a stake of 2,500 shares — an estimated $478K sold.

APG Asset Management first reported a position in MEDP in Q4 2018 and held it in 9 quarters. The position peaked at $48.6M in Q4 2019. 348 funds tracked by Wall St. Rank hold MEDP as of Q1 2022.

  • APG Asset Management reported no remaining Medpace position as of Q1 2022 after selling out during the quarter.
  • APG Asset Management sold 2,500 Medpace shares in Q1 2022, an estimated $478K.
  • APG Asset Management first reported a position in Medpace in Q4 2018 and held it in 9 quarters.
  • APG Asset Management's Medpace position peaked at $48.6M in Q4 2019.
  • 348 funds tracked by Wall St. Rank held Medpace as of Q1 2022.

Based on APG Asset Management's 13F filing for Q1 2022, filed 12 May 2022.